|
WO2020252365A1
|
|
Systems and methods to predict increased risk for adverse cardiovascular events in human immunodeficiency virus (hiv)-infected subjects
|
|
US2020060262A1
|
|
Methods to reduce clot formation in cold-stored platelet products
|
|
WO2019152878A1
|
|
Antibody screens using transgenic antigen(s)
|
|
US2019117694A1
|
|
Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipients
|
|
CA3015457A1
|
|
Methods to reduce clot formation in cold-stored platelet products
|
|
WO2018022722A1
|
|
Methods and systems for blood donor assessment
|
|
CA3025799A1
|
|
Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipients
|
|
WO2017192900A2
|
|
Methods of predicting post-transfusion survival of red blood cells
|
|
CA3014064A1
|
|
Therapeutic induction of tolerance using recombinant cell surface antigens
|
|
CA2999866A1
|
|
Composition and methods for assessing sensitivity and specificity of antibody detection reagents
|
|
CA2999097A1
|
|
Biochemical predictors of red blood cell quality
|
|
US2018317466A1
|
|
Mice with a modified glucose-6-phosphate dehydrogenase gene
|
|
US2016271179A1
|
|
Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipients
|
|
CA2982130A1
|
|
Biochemical mediators of platelet storage
|
|
US2017202963A1
|
|
Methods of Preventing Platelet Alloimmunization and Alloimmune Platelet Refractoriness and Induction of Tolerance in Transfused Recipients
|
|
CA2957429A1
|
|
Dicarboxylic acids and correlated compounds as a measure of red blood cell quality
|
|
US2017219598A1
|
|
Determination of small-molecule thiols and disulfides: protein bound cys and total cysteine as biomarkers of oxidative stress
|
|
CA2956072A1
|
|
Antibodies that recognize red blood cell antigens
|
|
US2017276665A1
|
|
Steap3 as a biochemical marker of red blood cell storage and toxicity
|
|
WO2015154090A1
|
|
Routine laboratory and point-of-care (poc) testing for hemostasis
|
